Cediranib Phase II Study in Children with Metastatic Alveolar Soft Part Sarcoma (ASPS).

BACKGROUND: ASPS, a rare vascular sarcoma with clinically indolent course, frequently presents with metastases. Vascular endothelial growth factor (VEGF) is a promising therapeutic target. In a phase II trial of the VEGF receptor inhibitor cediranib for adults with ASPS, the partial response (PR) ra...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pediatr Blood Cancer
Main Authors: Cohen, Julia W., Widemann, Brigitte C., Derdak, Joanne, Dombi, Eva, Goodwin, Anne, Dompierre, Jessica, Onukwubiri, Uzoma, Steinberg, Seth M., Coyne, Geraldine O’Sullivan, Kummar, Shivaani, Chen, Alice P., Glod, John
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803032/
https://ncbi.nlm.nih.gov/pubmed/31502400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.27987
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki